The use of GnRH analogs for induction of the preovulatory gonadotropin surge in assisted reproduction and prevention of the ovarian hyperstimulation syndrome

References

• Balasch J., Gómez F., Casamitjana R., Carmona F., Rivera F., Vanrell J. A. Pituitary–ovarian suppression by the standard and half doses of D-Trp-6-luteinizing hormone-releasing hormone depot. Hum. Reprod. 1992; 7: 1230–4
   PubMed Web of Science ®Google Scholar
• Simon A., Benshushan A., Shushan A., Zajicek G., Dorembus D., Lewin A., Laufer N. A comparison between a standard and reduced dose of D-Trp-6-luteinizing hormone-releasing hormone administered after pituitary suppression for in-vitro fertilization. Hum. Reprod. 1994; 9: 1813–17
   PubMedGoogle Scholar
• Scheele F., Hompes P. G. A., Lambalk C. B., Schoute E., Broekmans F. J. M., Schoemaker J. The gonadotropin releasing hormone (GnRH) challenge test: a yardstick to quantify pituitary desensitization during GnRH-agonist administration. Clin. Endocrinol. 1995, in press
   Google Scholar
• Chang R. J., Jaffe R. B. Progesterone effects on gonadotropin release in women pretreated with estradiol. J. Clin. Endocrinol. Metab. 1978; 47: 119–25
   PubMedGoogle Scholar
• Broekmans F. J. M., Hompes P. G. A., Schats R., Schoemaker J. Short term GnRH agonist treatment: dose related effects of triptorelin on pituitary function. Hum. Reprod. 1994; 9(Suppl. 4)154
   Google Scholar
• Schwartz M., Jewelewicz R. The use of gonadotropins for induction of ovulation. Fertil. Steril. 1981; 35: 3–12
   PubMed Web of Science ®Google Scholar
• Jewelewicz R., James S. L., Finster M., Dyrenfurth I., Warren M. P., Vande Wiele R. L. Gestation after ovulation induction with menopausal gonadotropins and pituitary luteinizing hormone. Obstet. Gynecol. 1972; 40: 1–5
   PubMedGoogle Scholar
• Nakano R., Mizuno T., Kotsuji F., Katayama K., Washio M., Tojo S. ‘Triggering’ of ovulation induction after infusion of synthetic luteinizing hormone releasing factor (LRF). Acta Obstet. Gynecol. Scand. 1973; 52: 269–72
   PubMed Web of Science ®Google Scholar
• Keller P. J. Treatment of anovulation with synthetic luteinizing hormone-releasing hormone. Am. J. Obstet. Gynecol. 1973; 116: 698–705
   PubMedGoogle Scholar
• Breckwoldt M., Czygan P. J., Lehman F., Bettendorf G. Synthetic LH-RH as a therapeutic agent. Acta Endocrinol. (Copenh.) 1974; 75: 209–20
   PubMedGoogle Scholar
• Crosignani P. G., Trojsi L., Attanasio A., Tonani E., Donini P. Hormonal profiles in anovulatory patients treated with gonadotropins and synthetic luteinizing hormone-releasing hormone. Obstet. Gynecol. 1975; 46: 15–22
   PubMedGoogle Scholar
• Itskovitz J., Boldes R., Barlev A., Erlik Y., Kahana L., Brandes J. M. The induction of LH surge and oocyte maturation by GnRH analog (buserelin) in women undergoing ovarian stimulation for in vitro fertilization. Gynecol. Endocrinol. 1988; 2(Suppl. 2)165
   PubMedGoogle Scholar
• Itskovitz J., Boldes R., Levron J., Erlik Y., Kahana L., Brandes J. M. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil. Steril. 1991; 56: 213–20
   PubMed Web of Science ®Google Scholar
• Lanzone A., Fulghesu A. M., Apa R., Caruso A., Mancuso S. LH surge induction by GnRH agonist at the time of ovulation. Gynecol. Endocrinol. 1989; 3: 213–20
   PubMed Web of Science ®Google Scholar
• Gonen Y., Balakiar H., Powell W., Casper R. F. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J. Clin. Endocrinol. Metab. 1990; 71: 918–22
   PubMed Web of Science ®Google Scholar
• Imoedemhe D. A. G., Sigue A. B., Pacpaco E. L. A., Olazo A. B. Stimulation of endogenous surge of luteinizing hormone with gonadotropin-releasing hormone analog after ovarian stimulation for in vitro fertilization. Fertil. Steril. 1991; 55: 328–32
   PubMed Web of Science ®Google Scholar
• Emperaire J. C., Ruffie A. Triggering ovulation with endogenous luteinizing hormone may prevent ovarian hyperstimulation syndrome. Hum. Reprod. 1991; 6: 506–10
   PubMed Web of Science ®Google Scholar
• Segal S., Casper R. F. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization. Fertil. Steril. 1992; 57: 1254–8
   PubMed Web of Science ®Google Scholar
• van der Meer S., Gerris J., Joostens M., Tas B. Triggering of ovulation using a gonadotropin-releasing hormone agonist does not prevent ovarian hyperstimulation syndrome. Hum. Reprod. 1993; 8: 1628–31
   PubMed Web of Science ®Google Scholar
• Scott R. T., Bailey S. A., Kost E. R., Neal G. S., Hofmann G. E., Illions E. H. Comparison of leuprolide acetate and human chorionic gonadotropin for the induction of ovulation in clomiphene citrate-stimulated women. Fertil. Steril. 1994; 61: 872–9
   PubMedGoogle Scholar
• Balasch J., Tur R., Creus M., Buxanderes R., Fabregues F., Ballesca J. L., Barri P. N., Vanrell J. A. Triggering of ovulation by a gonadotropin releasing hormone agonist in gonadotropin-stimulated cycles for prevention of ovarian hyperstimulation syndrome and multiple pregnancy. Gynecol. Endocrinol. 1994; 8: 7–12
   PubMed Web of Science ®Google Scholar
• Gerris J., De Vits A., Joostens M., Van Royen E. Triggering of ovulation in human menopausal gonadotropin-stimulated cycles: comparison between intravenously administered gonadotropin releasing hormone (100 and 500 μg) GnRH agonist (buserelin 500 μg) and human chorionic gonadotropin (10 000 IU). Hum. Reprod. 1995; 10: 56–62
   PubMedGoogle Scholar
• Wada I., Matson P. L., Troup S. A., Hughes S., Buck P., Lieberman P. A. Outcome of treatment subsequent to elective cryopreservation of all embryos from women at risk of the ovarian hyperstimulation syndrome. Hum. Reprod. 1992; 7: 962–6
   PubMedGoogle Scholar
• Khoury C., Itskovitz-Eldor J., Bar-Ami S. Induction of maturation of cumulus–oocyte complex by gonadotropin releasing hormone analogue is associated with lower progesterone secretion. J. Clin. Endocrinol. Metab. 1994; 79: 1001–7
   PubMedGoogle Scholar
• Itskovitz-Eldor J., Levron J., Kol S. Use of gonadotropin-releasing hormone agonist to cause ovulation and prevent the ovarian hyperstimulation syndrome. Clin. Obstet. Gynecol. 1993; 36: 701–10
   PubMedGoogle Scholar